Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Instillation with EMDA for OAB
NCT02735499Phase 2Completed
- Sponsor
- Sykehuset i Vestfold
- Start
- Mar 2016
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Sykehuset i Vestfold. Started Mar 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02735499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735499.